Connection

Search Results to Rebecca Miksad, MD

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Miksad, Rebecca

PropertyValue
Research Expertise & Professional Interests Rebecca Miksad is a medical oncologist and health outcomes researcher who serves as senior medical director at Flatiron Health. In this role, Rebecca focuses on generating real-world evidence, establishing regulatory-grade quality standards and contributing to the development of clinically-relevant methods to real-world data evaluation and analyses. Rebecca maintains a clinical practice at Boston Medical Center. A nationally recognized clinician and researcher, Rebecca regularly publishes in leading medical journals, serves on national committees and lectures internationally. Prior to joining Flatiron Health, Rebecca was an assistant professor at Harvard Medical School, senior scientist at the Institute for Technology Assessment at Massachusetts General Hospital, and director of gastrointestinal oncology and gastrointestinal oncology clinical trials at Beth Israel Deaconess Medical Center (BIDMC). Rebecca’s academic research focused on improving cancer treatment decision-making through better characterization of patient outcomes and increasing relevance of clinical trial endpoints. Rebecca earned a BA cum laude in economics from Harvard University and an MD with honors in research from Cornell University. She was a resident in internal medicine at Cornell University/New York-Presbyterian Hospital, and completed hematology and medical oncology fellowships at Harvard Medical School/BIDMC. Rebecca earned a MMS from Harvard Medical School and an MPH in Clinical Effectiveness from the Harvard School of Public Health in clinical effectiveness (with an emphasis on decision science). She also completed a post-doctoral fellowship in the Dana-Farber/Harvard Cancer Center Program in Cancer Outcomes Research Training (PCORT).

One or more keywords matched the following items that are connected to Miksad, Rebecca

Item TypeName
Concept Immunoglobulin Fc Fragments
Concept Immunohistochemistry
Concept Immunosuppressive Agents
Concept Immunotherapy
Concept Research Design
Concept Research Support as Topic
Concept Biomedical Research
Concept Translational Medical Research
Academic Article Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma.
Academic Article When a decision must be made: role of computer modeling in clinical cancer research.
Academic Article Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval.
Academic Article Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn''s disease.
Academic Article A Phase Ib, Open-Label Study of Dalantercept, an Activin Receptor-Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma.
Academic Article Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality.
Academic Article Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw.
Academic Article Safety of bevacizumab in patients with advanced cancer: a meta-analysis of randomized controlled trials.
Academic Article Small But Mighty: The Use of Real-World Evidence to Inform Precision Medicine.
Academic Article Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
Academic Article An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non-Small-Cell Lung Cancer.
Academic Article Real-world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non-small cell lung cancer.
Academic Article Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs.
Academic Article Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs.
Academic Article Association of Programmed Cell Death Ligand 1 Expression Status With Receipt of Immune Checkpoint Inhibitors in Patients With Advanced Non-Small Cell Lung Cancer.

Highlights
Search Criteria
  • immuno
  • oncology
  • research